BFSG »

Acelyrin shares owned by BFSG

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by BFSG from 13F filings

Historical chart of BFSG investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by BFSG consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by BFSG

Quarter filed Position value Share count Share price at filing
2024-12-31 $6.0k 1.9k 3.14
2024-09-30 $9.4k 1.9k 4.93
2024-06-30 $8.4k 1.9k 4.41

More positions owned by BFSG

Vanguard Index Fds Total Stk Mkt (VTI)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Gold Tr Ishares New (IAU)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Marvell Technology (MRVL)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Church & Dwight (CHD)
Raytheon Technologies Corp (RTX)
Vanguard World Energy Etf (VDE)
Etfs Gold Tr Physcl Gold Shs (SGOL)
Spdr Gold Tr Gold Shs (GLD)

View all positions for BFSG

Top funds holding Acelyrin

T. Rowe Price Investment Management
AyurMaya Capital Management Company
BlackRock
Millennium Management
Citadel Advisors
Vanguard Group
OrbiMed Advisors
venBio Partners
Tybourne Capital Management
Blue Owl Capital Holdings
General Atlantic
Samsara BioCapital
Morgan Stanley
Opaleye Management
Palo Alto Investors

View all funds holding Acelyrin